Soligenix
SNGX
#10244
Rank
โ‚ฌ10.85 M
Marketcap
1,08ย โ‚ฌ
Share price
-1.59%
Change (1 day)
-50.21%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -โ‚ฌ11.18 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ8.12 Million a decrease over its 2023 earnings that were of -โ‚ฌ6.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ11.18 Million37.71%
2024 -โ‚ฌ8.12 Million22.96%
2023 -โ‚ฌ6.6 Million-45.74%
2022 -โ‚ฌ12.16 Million11.88%
2021 -โ‚ฌ10.87 Million-32.37%
2020 -โ‚ฌ16.07 Million83.18%
2019 -โ‚ฌ8.78 Million11.57%
2018 -โ‚ฌ7.87 Million19.29%
2017 -โ‚ฌ6.6 Million33%
2016 -โ‚ฌ4.96 Million-19.7%
2015 -โ‚ฌ6.18 Million5.16%
2014 -โ‚ฌ5.87 Million
2010 -โ‚ฌ6.63 Million26.12%
2009 -โ‚ฌ5.26 Million75.1%
2008 -โ‚ฌ3 Million-45.38%
2007 -โ‚ฌ5.5 Million-22.84%
2006 -โ‚ฌ7.12 Million66.15%
2005 -โ‚ฌ4.29 Million-16.65%
2004 -โ‚ฌ5.14 Million13.28%
2003 -โ‚ฌ4.54 Million-11.88%
2002 -โ‚ฌ5.15 Million-59.44%
2001 -โ‚ฌ12.7 Million378.18%
2000 -โ‚ฌ2.66 Million-38.53%
1999 -โ‚ฌ4.32 Million-18.43%
1998 -โ‚ฌ5.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.11 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.28 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.89 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-โ‚ฌ15.76 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚ฌ36.25 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.86 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-โ‚ฌ2.39 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA